These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 38038121)
1. Sun R; Han M; Liu Y; Su Y; Shi Q; Huang L; Kong L; Li W; Li W Mol Med Rep; 2024 Jan; 29(1):. PubMed ID: 38038121 [TBL] [Abstract][Full Text] [Related]
2. Trpc6 knockout improves behavioral dysfunction and reduces Aβ production by inhibiting CN-NFAT1 signaling in T2DM mice. Kong L; Sun R; Zhou H; Shi Q; Liu Y; Han M; Li W; Qun S; Li W Exp Neurol; 2023 May; 363():114350. PubMed ID: 36791875 [TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rg1 attenuates glomerular fibrosis by inhibiting CD36/TRPC6/NFAT2 signaling in type 2 diabetes mellitus mice. Han Y; Su Y; Han M; Liu Y; Shi Q; Li X; Wang P; Li W; Li W J Ethnopharmacol; 2023 Feb; 302(Pt A):115923. PubMed ID: 36375645 [TBL] [Abstract][Full Text] [Related]
4. A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease. Ilatovskaya DV; Blass G; Palygin O; Levchenko V; Pavlov TS; Grzybowski MN; Winsor K; Shuyskiy LS; Geurts AM; Cowley AW; Birnbaumer L; Staruschenko A J Am Soc Nephrol; 2018 Jul; 29(7):1917-1927. PubMed ID: 29793963 [No Abstract] [Full Text] [Related]
5. Protective role of Trpc6 knockout in the progression of diabetic kidney disease. Spires D; Ilatovskaya DV; Levchenko V; North PE; Geurts AM; Palygin O; Staruschenko A Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1091-F1097. PubMed ID: 29923767 [TBL] [Abstract][Full Text] [Related]
6. Cortex Mori Radicis Attenuates Streptozotocin-induced Diabetic Renal Injury in Mice Zhai Y; Li D; Wang Z; Shao L; Yin N; Li W Endocr Metab Immune Disord Drug Targets; 2022; 22(8):862-873. PubMed ID: 35016601 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. Nijenhuis T; Sloan AJ; Hoenderop JG; Flesche J; van Goor H; Kistler AD; Bakker M; Bindels RJ; de Boer RA; Möller CC; Hamming I; Navis G; Wetzels JF; Berden JH; Reiser J; Faul C; van der Vlag J Am J Pathol; 2011 Oct; 179(4):1719-32. PubMed ID: 21839714 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of TRPC6 channels ameliorates renal fibrosis and contributes to renal protection by soluble klotho. Wu YL; Xie J; An SW; Oliver N; Barrezueta NX; Lin MH; Birnbaumer L; Huang CL Kidney Int; 2017 Apr; 91(4):830-841. PubMed ID: 27979597 [TBL] [Abstract][Full Text] [Related]
9. Palmitate induces human glomerular mesangial cells fibrosis through CD36-mediated transient receptor potential canonical channel 6/nuclear factor of activated T cell 2 activation. Su Y; Chen Q; Ju Y; Li W; Li W Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Dec; 1865(12):158793. PubMed ID: 32800850 [TBL] [Abstract][Full Text] [Related]
10. TRPC Channels in Proteinuric Kidney Diseases. Hall G; Wang L; Spurney RF Cells; 2019 Dec; 9(1):. PubMed ID: 31877991 [TBL] [Abstract][Full Text] [Related]
11. Knockout of TRPC6 promotes insulin resistance and exacerbates glomerular injury in Akita mice. Wang L; Chang JH; Buckley AF; Spurney RF Kidney Int; 2019 Feb; 95(2):321-332. PubMed ID: 30665571 [TBL] [Abstract][Full Text] [Related]
12. Canonical Transient Receptor Potential 6 Channel: A New Target of Reactive Oxygen Species in Renal Physiology and Pathology. Ma R; Chaudhari S; Li W Antioxid Redox Signal; 2016 Nov; 25(13):732-748. PubMed ID: 26937558 [TBL] [Abstract][Full Text] [Related]
13. Renal Fibrosis, Immune Cell Infiltration and Changes of TRPC Channel Expression after Unilateral Ureteral Obstruction in Trpc6-/- Mice. Kong W; Haschler TN; Nürnberg B; Krämer S; Gollasch M; Markó L Cell Physiol Biochem; 2019; 52(6):1484-1502. PubMed ID: 31099508 [TBL] [Abstract][Full Text] [Related]
14. TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription. Schlöndorff J; Del Camino D; Carrasquillo R; Lacey V; Pollak MR Am J Physiol Cell Physiol; 2009 Mar; 296(3):C558-69. PubMed ID: 19129465 [TBL] [Abstract][Full Text] [Related]
15. The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury. Verheijden KAT; Sonneveld R; Bakker-van Bebber M; Wetzels JFM; van der Vlag J; Nijenhuis T J Am Soc Nephrol; 2018 Aug; 29(8):2099-2109. PubMed ID: 29954830 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin II has acute effects on TRPC6 channels in podocytes of freshly isolated glomeruli. Ilatovskaya DV; Palygin O; Chubinskiy-Nadezhdin V; Negulyaev YA; Ma R; Birnbaumer L; Staruschenko A Kidney Int; 2014 Sep; 86(3):506-14. PubMed ID: 24646854 [TBL] [Abstract][Full Text] [Related]
17. The Effects of TRPC6 Knockout in Animal Models of Kidney Disease. Dryer SE; Kim EY Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421724 [TBL] [Abstract][Full Text] [Related]
18. Capsazepine (CPZ) Inhibits TRPC6 Conductance and Is Protective in Adriamycin-Induced Nephropathy and Diabetic Glomerulopathy. Hagmann H; Khayyat NH; Matin M; Oezel C; Chen H; Schauss A; Schell C; Benzing T; Dryer S; Brinkkoetter PT Cells; 2023 Jan; 12(2):. PubMed ID: 36672207 [TBL] [Abstract][Full Text] [Related]
19. Role of TRPC6 in Progression of Diabetic Kidney Disease. Staruschenko A; Spires D; Palygin O Curr Hypertens Rep; 2019 May; 21(7):48. PubMed ID: 31115705 [TBL] [Abstract][Full Text] [Related]
20. Transient receptor potential canonical 6 knockdown ameliorated diabetic kidney disease by inhibiting nuclear factor of activated T cells 2 expression in glomerular mesangial cells. Yu J; Li C; Ma L; Zhai B; Xu A; Shao D Ren Fail; 2022 Dec; 44(1):1780-1790. PubMed ID: 36285371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]